Viridium Pacific Group (CVE:VIR) Stock Price Up 5.6% – Time to Buy?

Viridium Pacific Group Ltd (CVE:VIRGet Free Report) shares traded up 5.6% on Monday . The company traded as high as C$0.41 and last traded at C$0.38. 26,500 shares were traded during trading, a decline of 71% from the average session volume of 92,632 shares. The stock had previously closed at C$0.36.

Viridium Pacific Group Stock Performance

The firm has a market capitalization of C$37.52 million and a P/E ratio of -2.97. The business has a fifty day moving average of C$0.38 and a 200-day moving average of C$0.38.

Viridium Pacific Group Company Profile

(Get Free Report)

Viridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use. Viridium Pacific Group Ltd. is headquartered in Mission, Canada.

Read More

Receive News & Ratings for Viridium Pacific Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viridium Pacific Group and related companies with MarketBeat.com's FREE daily email newsletter.